CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 18 enrolled
Drug / intervention
Phenylephrine Ophthalmic +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05890027
NCT05890027Phase 4Completed

Phenylephrine Versus Upper Eyelid Taping For Muller's Muscle Conjunctival Resection Evaluation

University of Miami·interventional·Posted Jun 5, 2023·Updated Aug 22, 2025

In Brief

A Phase 4 clinical trial evaluating Phenylephrine Ophthalmic and Eyelid Tape for Ptosis, Eyelid. Completed, enrolled 18 participants across 1 site.

Detailed Summary

This research study aims to compare whether Phenylephrine 2.5% ophthalmic eye drop solution can serve as a better indicator of the effect of a drooping upper eyelid (ptosis) by covering part of the upper portion of the field of vision as compared to traditional use of tape to lift up the upper eyelid in the evaluation of patients for surgical upper eyelid repair.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPtosis, Eyelid
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
202420252026
First PostedJun 5, 2023
Enrollment StartMar 19, 2024
Primary CompletionApr 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 3.1 years ago

Interventions

Phenylephrine Ophthalmicdrug

One drop of Phenylephrine 2.5% ophthalmic solution to be administered to the eye with ptosis to evaluate for surgical repair.

Eyelid Tapeother

Participants will have the affected eye with ptosis manually lifted using tape.